4D Molecular Therapeutics, Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Emeryville, CA
FDMT chart
What traders are saying about $FDMT
Latest posts4D Molecular Therapeutics, Inc. news
- Zoetis (ZTS) Q3 Earnings and Revenues Top Estimates
Yahoo Finance ·
- Will Journey Medical Corporation (DERM) Report Negative Q3 Earnings? What You Should Know
Yahoo Finance ·
- FDMT Q3'26 Earnings: revenue estimate is 4.13M USD
TradingView ·
- FDMT: 4D Molecular Therapeutics Inc Latest Stock Price, Analysis, News and Trading Ideas
Stocktwits ·
- 4DMT to Participate in Upcoming Investor Conferences
Yahoo Finance ·
- Seven conference talks are scheduled for 4DMT. Recordings will stay online for up to a year.
Stock Titan ·
- Stevanato Group (STVN) Surpasses Q3 Earnings and Revenue Estimates
Yahoo Finance ·
- 4D Molecular Therapeutics, Inc. (FDMT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Yahoo Finance ·
- 4D Molecular Therapeutics Targets Wet AMD Injection Burden With 4D-150 Gene Therapy
marketbeat.com ·
- Cystic Fibrosis Market Poised for Growth During the Forecast Period (2026-2036) as CFTR Modulators Transform Treatment Landscape | DelveInsight
Yahoo Finance ·
- 4DMT Announces New Employment Inducement Grants
Yahoo Finance ·
- 4DMT to Host Investor Day on October 21, 2026
Yahoo Finance ·
4D Molecular Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $85.2M | $37,000 | $20.7M | $3.1M |
| Net income | -$140.1M | -$160.9M | -$100.8M | -$107.5M |
| Diluted EPS | $-2.42 | $-2.98 | $-2.58 | $-3.32 |
| Total assets (year end) | $566.7M | $560.4M | $339.9M | $261.8M |
| Cash and equivalents (year end) | $60.2M | $149.3M | $249.1M | $52.4M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About 4D Molecular Therapeutics, Inc.
- Ticker
- FDMT (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Emeryville, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1650648
- Former names
- 4D Molecular Therapeutics Inc., 4D Molecular Therapeutics Inc
Frequently asked questions
What exchange is 4D Molecular Therapeutics, Inc. listed on?
4D Molecular Therapeutics, Inc. trades on the Nasdaq under the ticker symbol FDMT.
What industry is 4D Molecular Therapeutics, Inc. in?
4D Molecular Therapeutics, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is 4D Molecular Therapeutics, Inc. headquartered?
4D Molecular Therapeutics, Inc.'s business address on file with the SEC is in Emeryville, CA.
When does 4D Molecular Therapeutics, Inc.'s fiscal year end?
4D Molecular Therapeutics, Inc.'s fiscal year ends on December 31.
How much revenue did 4D Molecular Therapeutics, Inc. report?
4D Molecular Therapeutics, Inc. reported $85.2M in revenue for calendar year 2025, according to its SEC filings.